BACKGROUND: Fatty acid oxidation has frequently been measured using 13 C or 14 C labeled fatty acids. While providing valuable data, the breath test method is hindered by the need for a controlled environment to measure VCO 2 and collect frequent breath samples. Additionally, the CO 2 breath tests require the use of 13 C-or 14 C-acetate to correct for isotope exchange in the TCA cycle. We validated d 31 -palmitic acid for measuring dietary fat oxidation. When oxidized, the deuterium appears as water and mixes with the body water pool providing a cumulative record of fat oxidation. METHODS: The recovery of deuterium from d 31 -palmitic acid at 10 h post-dose was compared to that of 13 C]-palmitic acid recovery was 6.4 AE 3.6%. When the 13 C data was corrected for [1-13 C]-acetate (Na salt) recovery, the mean difference in percentage recovery between the two tracers was 0.5 AE 2.8% and cumulative recoveries through 10 h post-dose were highly correlated (y ¼ 1.045x 7 0.47; r 2 ¼ 0.88, P < 0.0002). Our data shows both labels to be equivalent in their ability to measure dietary fat oxidation in resting subjects. CONCLUSIONS: The use of deuterium labeled palmitic acid eliminates the need for rigid control over the subjects' environment. Frequent sampling and measurement of VCO 2 are not needed for accurate calculation of percentage recovery of the deuterium label. In addition, the deuterium label has a decreased potential for isotopic exchange compared to 13 C or 14 C, so a recovery correction factor is probably not required.
Introduction
The stable isotope 13 C has been used for measuring fat oxidation for the past few decades. 1 -4 It has been given by constant infusion to measure plasma fat oxidation and orally to measure dietary fat oxidation. While the latter makes use of tracer technology to differentiate between exogenous and endogenous fats, both types of applications are aimed at quantification of some aspect of fat oxidation. In each setting, the 13 C fatty acid oxidation is measured based on the ratio of 13 CO 2 above baseline in breath. Despite the advantages and ease of the technique, some limitations still exist with the use of 13 C-labeled fatty acids. A controlled environment is needed for frequent collection of breath samples. For accurate analysis, respiratory gas exchange measurements are necessary because the CO 2 flux is needed to calculate 13 C recovery, which requires access to either a metabolic cart or a human respiratory chamber. Methods of obtaining VCO 2 are not only time consuming but also result in greater subject involvement and restriction of daily activity. A second limitation of the 13 C method is the need for frequent breath sampling, again interfering with free-living conditions. Lastly, the use of 13 C-labeled fatty acids may be limited due to the potential for isotopic exchange of 13 C at several steps along the TCA cycle. 5, 6 The exchange of label results in a decrease in 13 CO 2 excretion and, therefore, an underestimation of fatty acid oxidation. A solution to this problem has been to correct fatty acid recovery with the recovery of 13 C-acetate. 5 -8 Given the limitations of 13 CO 2 breath tests, the development of an alternative method would be useful. The use of deuterium labeling may serve as such an alternative. Tritium has been used by researchers in the past, but the use of radioactivity is not always feasible. 9, 10 The loss of label in the TCA cycle is virtually eliminated when deuterium is used rather than 13 C and therefore should not require a correction for exchange reactions. Deuterium eliminates the need for frequent sampling as well as the measurement of VCO 2 . When oxidized, 2 H appears as H 2 O and mixes with the body water pool. Other than minimal losses (7%=day) as urine and insensible water, 11 the remainder of the label should provide a cumulative record of fat oxidation measurable in urine.
The aim of this study was to validate the use of deuterated labeling of fatty acids to measure dietary fat oxidation. The null hypothesis to be tested is that recovery of 13 C to insure mixing. On day 2, subjects were also given a dose of 10 atom% 18 O as water at a dose of 0.2 g=kg. Both test days were similar except for the specified tracers. Subjects reported to the laboratory at 07:30 after an overnight fast. Baseline breath and urine samples were collected, and drinks containing the labeled materials were given orally as part of a liquid replacement meal at 08:00. Subjects remained in the laboratory until 16:00. Meals were provided and consisted of replacement meals and nutrient bars given at the subjects' estimated energy expenditure using BEE calculated from the WHO equation 12 multiplied by an activity factor of 1.5. Meals were provided at 08:00 and 12:00, and were 50% carbohydrate, 35% fat and 15% protein. The 08:00 liquid meal provided 20% and the 12:00 meal 30% of each subject's estimated energy requirement for the day. Respiratory gas exchange was measured while the subjects were quietly sitting upright for 20 min out of each hour using the Delta Trac metabolic cart (Sensor Medics, Yorba Linda, CA). The O 2 and CO 2 analyzers were calibrated with a standard gas containing 96% O 2 and 4% CO 2 . A mouthpiece was attached to a two way non-rebreathing t-shaped valve and a noseclip to ensure that all gas exchange was through the mouth (Hans Rudolph, Kansas City, MO). The valve was exhausted into the Delta Trac ventilated canopy system for measurement of respiratory gases. VCO 2 values were extrapolated to represent an average CO 2 production for the hour corresponding to the breath sample time.
Sample collection and analysis On both days, breath samples for the collection of 13 CO 2 were taken hourly by having subjects blow through a straw into a 15 ml Vacutainer TM , which was then capped (Becton Dickinson, Franklin Lakes, NJ). Breath CO 2 was sampled directly from the Vacutainer TM with a syringe and 13 CO 2 = 12 CO 2 was measured with continuous flow IRMS (Delta S, Finnigan MAT, Bremen, Germany).
13 CO 2 was introduced into a helium stream onto choromosorb-Q to separate CO 2 from the less polar gases and directed into the source of the isotope ratio mass spectrometer (IRMS). 13 Each sample was injected twice for isotope ratio analyses. The average standard deviation for all injections was 0.10%. Isotopic enrichment was determined relative to a tank calibrated CO 2 standard. Excess 13 C was calculated relative to O were measured in urine samples collected every 4 h after dosing. Urine (5 ml) was mixed with 200 mg carbon black to remove impurities and filtered through a 0.45 mm filter. One milliliter of urine was placed into autosampler vials and deuterium was measured with IRMS. Urine samples were analyzed for deuterium content as a ratio of 2 H= 1 H using the Delta Plus mass spectrometer (Finnigan MAT, Bremen, Germany). From each 1 ml of sample, 0.8 ml were injected into a quartz tube packed with chromium powder held at 850 C to reduce the water to hydrogen gas. Each run included three injections of the sample with independent analysis. Data were corrected for both H 3þ and memory. Results were corrected to the Standard Mean Ocean Water (SMOW) scale. A second 1 ml of clean urine was allowed to equilibrate with CO 2 at 25 C for 48 h. The 18 O concentration was measured by continuous flow IRMS and the body water was calculated by dilution.
11,13
Label calculations Recovery of the stable isotopes was calculated at 2, 6, and 10 h post-dose. For the labeled subjects, one baseline breath= urine sample was taken each day before ingesting the dose. This value was subtracted from the subsequent dose values for each subject, so that each time point is expressed as a per mille* increase above the subjects' own baseline (Dd). The control subjects' averaged values were subtracted from those of the labeled subjects to correct for background variation. This resulted in values that were adjusted for each individual's baseline as well as meal related natural background variation.
Total CO 2 production was obtained from the respiratory gas exchange measurements and total excess 13 C expressed as amount of dose recovered during each hour. C-acetate at 8 h post-dose had not quite returned to baseline as had been expected, the terminal elimination rate was extrapolated from 8 to 10 h to allow for calculation of the 10 h 13 Cpalmitate value. The average cumulative percentage dose recovery between 8 and 10 h from acetate was small (1.8 AE 0.9%).
Recovery of deuterium from palmitic acid oxidation was calculated as excess 2 H times TBW divided by the dose of 2 H administered:
Statistical analysis
14 The difference between 2 H and 13 C percentage recovery was plotted against the average recovery of the two isotopes. Bias and precision were evaluated using the mean and s.d. of the difference between the labeled fatty acid oxidation. The limits of agreement were defined as the mean difference AE 2 s.d. A regression analysis was completed followed by a paired Student's t-test quantifying the strength of the relationship between the two methods. All analyses were performed with Statview 5.0.1 (SAS Institute, Cary, NC) and significance was set at a P < 0.05.
Results
Peak recovery of 13 (Figure 3 ). The mean difference between the methods is 0.08 AE 2.8%, implying that both measurements are accurate. All points on the plot fall within AE 2 s.d., which suggests that random error was minimal.
Discussion
Our study showed that the deuterium labeled fatty acid is a valid method of measuring dietary fat oxidation when compared to the traditional 13 C label in subjects at rest. Deuterium labeling offers several advantages over the use of 13 C. When deuterium is used, a large acetate correction factor for the calculation of recovery is no longer needed. In addition, Deuterium labeling for measuring fat oxidation SB Votruba et al deuterium can be used in free-living conditions with decreased sampling frequency and no VCO 2 measurements.
The use of deuterium labeling minimizes the opportunity for loss of tracer. Inspection of the reactions occurring during b-oxidation and acetate metabolism demonstrate this ( Figure  4 ). The 13 C has a greater potential for isotopic exchange. The 13 C-free fatty acid (FFA) goes through b-oxidation, with acetyl-CoA units being sent to the TCA cycle. From the TCA cycle, one would expect that the 13 C label leaves the system as 13 CO 2 in the breath. Unfortunately, there are several sites in the TCA cycle where isotopic exchange may occur. As suggested by Sidossis et al, 5, 6 label may be temporarily lost through oxaloacetate to pyruvate=lactate and possibly glucose. Label may also be lost through conversion of a-ketoglutarate to glutamate=glutamine, resulting in temporary label fixation in the amino acid or protein pool. This problem can be corrected with the use of the 13 C-acetate. 5, 6 When entering the cell, acetate is directly converted to acetyl-CoA and directly enters the TCA cycle. The fraction of acetate retained in the body is equal to the amount of label fixed through exchange in the TCA cycle.
In contrast, the 2 H label is removed from the fatty acids during b-oxidation and the TCA cycle as flavoproteins, NADH þ H þ and FADH 2 , which enter the respiratory chain and are oxidized to body water (Figure 4) . The first step of boxidation is dehydration catalyzed by acyl-CoA dehydrogenase. In this step, two 2 H are eliminated and oxidize to water. In the next step (hydration with enoyl-CoA hydratase), H 2 O adds an unlabeled H bond to the fatty acid. Two more hydrogens are eliminated during the next dehydration step. These hydrogens may be either labeled or unlabeled. If one of the deuteriums remains on the acetyl-CoA that enters the TCA cycle, then the 2 H may be lost when carbon isotopic exchange occurs. The 2 H may still be incorporated into NADH þ H þ and FADH 2 in several reactions of the TCA cycle. Since at least 75% of the hydrogens for each acetylCoA are already shuttled to the respiratory chain in b-oxidation, only one-fourth of the labeled H has the potential for exchange during transit through the TCA cycle. The [1-
13 C]-acetate recovery in our study suggests that $ 50% of the label remains sequestered at 10 h post-dose. We thus predict that only 12% (50% of 25%) of the labeled H from fatty acid oxidation could be lost in the TCA cycle.
Though the acetate correction factor was initially done with 14 C-acetate given on the same day as the 13 C-FFA, 6 later evidence suggests that 13 C-acetate may be used on a separate day to make the correction if test conditions are reproduced. 7 Schrauwen et al infused [1,2-13 C]-acetate in six subjects on two different days (2 -4 weeks apart) to determine intrasubject reproducibility of the measurements. In those subjects, no differences in 13 C recovery and a high correlation between the two days were seen at all time points. They reported the mean percentage difference in acetate recovery in each subject between the two tests to be 5.4%, with an intrasubject coefficient of variation over the infusion time of 4.0 AE 1.5%. This implies that, even when measured on a different test day, the within subject recovery variability in 13 C from acetate is smaller than the between individual variation and it is valid to use a separate test day to measure the 13 C-acetate recovery and eliminate the use of radiolabels. Schrauwen et al caution that a separate correction factor needs to be determined for each subject in a study due to the high inter-individual variability in the recovery of 13 C-acetate (coefficient of variance ¼ 8.3 AE 0.6%). 7 In our data, however, there was no statistical difference between using a group mean correction and an individual correction. Indeed, the fit of the regression line between the 13 C and 2 H measures was better using the group correction. This may, however, be specific to our small sample of individuals. Our methods also differ from previous studies employing the acetate correction factor. We give all of our labels orally and measure recovery over longer time periods, while most studies use short infusion periods. The short-term kinetics of acetate may be more variable than the long-term recovery.
The use of 2 H-labeled FFA is highly advantageous when compared to 13 C-FFA because they have the potential to be used in free-living conditions. A controlled environment is no longer necessary and samples do not have to be taken as frequently. We only required a urine sample from our subjects once every 4 h. If only a 24 h dietary fat oxidation value is desired, one could potentially only require two samples from each subject: baseline and enriched. A potential disadvantage does exist for the recovery of the deuterium label in the urine. If a protocol requires frequent measurements, it may be difficult to obtain a large number of urine samples from some subjects. In that case, plasma or saliva samples may be used as an alternative. Saliva, however, requires that care be taken to reduce fractionation secondary to evaporation prior to collection.
Another major advantage with the deuterium label is that measurement of VCO 2 is not needed to calculate recovery. It is, however, necessary to measure the water pool size of a subject. This can be done without tracer interference through the use of 18 O dilution. 11, 13 The
18
O enrichment can be measured from the same urine sample used to analyze deuterium. Again, plasma or saliva samples may be used. If, as may be the case, 18 O is not readily available, several other methods of measuring TBW exist. Any one of these methods may be used, as long as error inherent in that particular measurement is kept in mind.
When using deuterium tracers, however, it is important to be aware of potential label sequestration into ketone bodies. During periods of low glycogen availability, the liver converts acetyl-CoA resulting from b-oxidation of fatty acids into acetoacetic acid and b-hydroxybutric acid. About $ 75% of the deuterium will be released to water during b-oxidation, but the carbon and remaining hydrogen will be converted into ketone bodies. Formation of ketone bodies can result in discrepancies between 13 C and deuterium when measuring fatty acid oxidation, when the ketone body pool size increases, or when ketones are spilled into the urine. In normal healthy individuals, the average plasma levels of Deuterium labeling for measuring fat oxidation SB Votruba et al acetoacetate and b-hydroxybutyrate are $ 100 and 300 mmol=l, respectively, and urinary excretion is effectively zero. 15 Over a 48 h fast, plasma ketone concentrations can increase by $ 2.5 mM=l. 16 If we assume average ketones to have four carbons, then this corresponds to about 1.2 g=day of long chain FA being sequestered into ketones in a reference male (ECF ¼ 14 l). When a FA tracer dose is given in a 500 kcal meal (35% energy as fat), $ 9.7 g=day of fat is being administered. Ignoring the contribution of endogenous FA, this would lead to, at most, a 6% loss of dose per day into the enlarging ketone pool. In situations of severe ketoacidosis, plasma ketone levels may increase to 14 mM=l. 16 If urine concentration is assumed to equal plasma concentration, and urine output is assumed to be 2 l=day, then $ 1.8 g=day of FA may be lost. In a situation where tracer is infused at 10% of endogenous FFA production, at most 0.1% per day loss can occur in urine. These situations are rare, however, and are unlikely to be problematic for metabolic studies in normal individuals. Of course since the fate of most ketone bodies is oxidation, the carbon and remaining hydrogen labels will be released as 13 CO 2 and 2 H 2 O and represent substrate oxidation despite the different route of oxidation. 6 In conclusion, we found that the deuterium label eliminates many of the problems encountered when using 13 C to measure dietary fat oxidation. Deuterium can be used in freeliving, resting subjects with minimal sampling times, no VCO 2 measurement is required, cost is minimal, and no correction factor is needed. Further studies that validate the use of deuterium labeled fatty acids during non-resting conditions are necessary. Incidentally, the use of deuterium in this study also confirms the need for the acetate correction factor when using the 13 C label. The relatively minimal chance for exchange of deuterium suggests that the oxidation of the label represents an accurate estimation of dietary fat oxidation.
